By PTI
HYDERABAD: The Brazilian government, which agreed to purchase 20 million doses of Bharat Biotech’s COVID-19 vaccine Covaxin, on Wednesday announced suspension of the contract following allegations of irregularities in the deal.
“By recommendation of @CGUonline, we decided to temporarily suspend the Covaxin contract.
According to CGU’s preliminary analysis, there are no irregularities in the contract, but, due to compliance, the @minsaude opted to suspend the contract for further analysis,” Brazil Health Minister Marcelo Queiroga tweeted.
ALSO READ | Covaxin effectively neutralises Delta variant of Covid, says top US health institute
The Covaxin contract to Brazil landed in controversy after the South American countrys Attorney General reportedly launched a probe into the deal.
“It is noteworthy that the @govbr did not pay ANY CENT for the Covaxin vaccine. The measure does not compromise the pace of the vaccination campaign against #Covid19 in Brazil, since there is no approval from Anvisa for emergency or definitive use of the immunizing agent,” Queiroga said in another tweet.
ALSO WATCH: